股票代碼
000661
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical ind西窗ustry
Real-estate development
Innovation
News
Investor
Stock information
Company governa舞年nce
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibi照銀lity
Public welfare
CN
About
Group introduction
Leading teams
Organizational chart飛志
Enterprise cultu海低re
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement可什
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
To stimulate the potential樂看 of life so that life 飛請blossomed in the hone
Investor
Periodical report
城月 美大 Company a聽兒nnouncement 你如 我白 多坐 離懂 劇說
Interactive platform
CN
Stock information
Company governance
Periodical report
Company announcement區高
Interactive platform
Home
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development stra可樹tegy
Honor qualificatio見月n
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of respo空得nsibility
Public welfare
Total
1,913
announcements
關于2022年限制性股票與股票期權激勵計劃部分股票期權注銷完們我成(chéng)的公告
2023-12-02
關于召開(kāi)2023年第三次臨時銀懂(shí)股東大會(huì)的通知
2023-11-28
董事(shì)會(huì)提名委器費員會(huì)工作細則（2023年11月修訂）
2023-11-28
獨立董事(shì)關于第十屆董事(s關草hì)會(huì)第三十次會(huì)議相關事(shì)項的獨立意見什機
2023-11-28
關于監事(shì)辭職及補選監事(shì)的公告
2023-11-28
董事(shì)會(huì)審計委員會(huì)工作細則（2023年11月修訂有在）
2023-11-28
關于控股子公司GS1-144片臨床試驗申請獲得批準的公告
2023-11-28
北京市康達律師事(shì)務所關于淨月高新技術産業一計開(kāi)發(fā)區樂帆服務中心2022年限生遠制性股票與股票期權激勵計劃回購注銷部分已獲授但尚未解除限售限子麗制性股票以及注銷部分已獲授但尚未行權股票期權相關事(s黑低hì)項的法律意見書
2023-11-28
第十屆監事(shì)會(huì)第二十次會(huì)議決議公告
2023-11-28
關于控股子公司重組人促卵泡激素-CTP融合蛋白注射液臨床試驗申話很請獲得批準的公告
2023-11-28
關于回購注銷部分2022年限制性股票與股票期權激內志勵計劃激勵對(duì)象已獲授但尚未解除限售限制性股票的公告到我
2023-11-28
關于注銷部分2022年限制性股票與股票影照期權激勵計劃激勵對(duì)象已獲授但尚未行權股票期權的公告
2023-11-28
第十屆董事(shì)會(huì)第三十次會(huì開討)議決議公告
2023-11-28
監事(shì)會(huì)關于回購注銷部分限制性股票及注章煙銷部分股票期權的審核意見
2023-11-28
關于部分董事(shì)、監事(shì)、高級管理人員增持公司股份的公告
2023-11-28
上一頁
1
2
3
4
5
6
7
8
下一頁
